In this episode, we visit with Christopher Furmon who leads Vitro based in Colorado. Christopher doesn't come from a traditional biopharma track. Instead, he spent decades helping build the financial juggernaut Janus.
Vitro Biopharma has a goal to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market; and ultimately, to address well-established multi-billion-dollar commercial markets.
The team has over 30 years of drug discovery and development experience that has enabled them to identify and advance multiple product candidates from preclinical studies into clinical trials. Specifically, their extensive knowledge of immunology and inflammatory conditions informs their decision making to advance the scientific and clinical path to demonstrate proof-of-concept, with the goal of achieving an efficient timeframe and cost-effective budget. Visit them at www.vitrobiopharma.com
In this episode, Ryan Khanna, MD, MBA co-hosts a discussion with Robert Eastlack who runs a premier surgical spine practice in San Diego, CA...
This is a quick episode to describe what to expect from the Innovation4Alpha podcast hosted by Tobin Arthur.
With Sage’s AI Driven Medical Coding, Billing and Dictation, practitioners are eliminating the costly overhead of a medical coder while increasing productivity by 20%....
